Rates, amounts, and determinants of ambulatory blood pressure monitoring claim reimbursements among Medicare beneficiaries

scientific article

Rates, amounts, and determinants of ambulatory blood pressure monitoring claim reimbursements among Medicare beneficiaries is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JASH.2014.09.020
P932PMC publication ID4262764
P698PubMed publication ID25492833
P5875ResearchGate publication ID267761011

P50authorSuzanne OparilQ30029225
Anthony J VieraQ41172215
Keith M DiazQ84372625
Meredith KilgoreQ88244081
Paul MuntnerQ90572515
Daichi ShimboQ98526959
Shia T KentQ114414594
P2093author name stringLei Huang
P2860cites workMeasuring diagnoses: ICD code accuracyQ24537540
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>Q28204197
2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)Q29617334
Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient dataQ30926045
Unmasking masked hypertension: prevalence, clinical implications, diagnosis, correlates and future directions.Q34051241
Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazoneQ34123137
Is ambulatory blood pressure monitoring cost-effective in the routine surveillance of treated hypertensive patients in primary care?Q34224324
Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses AssociationQ34338939
Epidemiology of masked and white-coat hypertension: the family-based SKIPOGH studyQ35129492
Hospital characteristics related to the intention to apply for meaningful use incentive paymentsQ35896593
Ambulatory blood-pressure monitoringQ36493993
Significance of white-coat hypertension in older persons with isolated systolic hypertension: a meta-analysis using the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes populationQ36713745
Age and the difference between awake ambulatory blood pressure and office blood pressure: a meta-analysisQ37339098
Cost-effectiveness of secondary screening modalities for hypertensionQ37651806
Resistant hypertension: a review of diagnosis and management.Q38217294
Hospital IT adoption strategies associated with implementation success: implications for achieving meaningful use.Q39861750
Use of electronic health records in U.S. hospitalsQ39879070
When and how to use self (home) and ambulatory blood pressure monitoringQ39881998
Cost-effectiveness of ambulatory blood pressure: a reanalysisQ40365892
Treated hypertension and the white coat phenomenon: Office readings are inadequate measures of efficacyQ42693608
White coat effect and its clinical implications in the elderlyQ43265554
Management of hypertension: summary of NICE guidanceQ46608322
Three payer strategies to increase revenueQ47751309
Appropriate time interval to repeat ambulatory blood pressure monitoring in patients with white-coat resistant hypertension.Q51458089
Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart AssociatiQ51542873
Prognosis of white-coat and masked hypertension: International Database of HOme blood pressure in relation to Cardiovascular Outcome.Q53096907
European Society of Hypertension Position Paper on Ambulatory Blood Pressure MonitoringQ57085349
Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. A randomized controlled trial. Ambulatory Blood Pressure Monitoring and Treatment of Hypertension InvestigatorsQ57085832
Cost analysis of ambulatory blood pressure monitoring in initiating antihypertensive drug treatment in Australian general practiceQ74300159
P433issue12
P407language of work or nameEnglishQ1860
P304page(s)898-908
P577publication date2014-10-02
P1433published inJournal of the American Society of HypertensionQ15816756
P1476titleRates, amounts, and determinants of ambulatory blood pressure monitoring claim reimbursements among Medicare beneficiaries
P478volume8

Reverse relations

cites work (P2860)
Q40112225Barriers to conducting ambulatory and home blood pressure monitoring during hypertension screening in the United States
Q57787236Diagnosing Masked Hypertension Using Ambulatory Blood Pressure Monitoring, Home Blood Pressure Monitoring, or Both?
Q50194085Implementing ABPM into Clinical Practice
Q46922060Insights in Public Health: Ambulatory Blood Pressure Monitoring: Underuse in Clinical Practice in Hawai'i
Q38966241Integrating Out-of-Office Blood Pressure in the Diagnosis and Management of Hypertension
Q58121798Number of Measurements Needed to Obtain a Reliable Estimate of Home Blood Pressure: Results From the Improving the Detection of Hypertension Study
Q28073632Practical Aspects of Home and Ambulatory Blood Pressure Monitoring
Q36264027Role of Ambulatory and Home Blood Pressure Monitoring in Clinical Practice: A Narrative Review
Q36913602Short-Term Risk of Serious Fall Injuries in Older Adults Initiating and Intensifying Treatment With Antihypertensive Medication

Search more.